Ryu Ogawa, Ph.D.

Ryu Ogawa is a co-founder and key executive at MOLCURE Inc., a company focused on accelerating drug discovery through artificial intelligence.12 He holds a Ph.D. and has a background in creating AI systems for biotechnology applications.6

Career at MOLCURE

Ogawa's role at MOLCURE has evolved over time:

• He co-founded the company in May 2013.4
• Initially, he served as the Representative Director and Chief Executive Officer (CEO).1
• As of April 8, 2024, he transitioned to the role of Board Director and Chief Innovation Officer (CIO).12

Educational Background

Ryu Ogawa received his education at the Tokyo Institute of Technology, completing his studies in August 2003.4

Professional Experience

Before founding MOLCURE, Ogawa worked as:

• A Co-Founder and Senior Architect at Synclogue Inc. starting in 2009.5
• A Lecturer at Keio University.3

Skills and Expertise

Ogawa's expertise lies in:

• Artificial Intelligence applications in biotechnology6
• Drug discovery and development7
• Biopharmaceutical research and innovation2

Language Proficiency

Ogawa is fluent in Japanese (native or bilingual proficiency) and has professional working proficiency in English.4

Ryu Ogawa's LinkedIn username is indeed ryu-ogawa-ph-d-91639aba, as mentioned in the query.47